# Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients

> **NCT03773952** · PHASE2 · COMPLETED · sponsor: **Palobiofarma SL** · enrollment: 34 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** PBF-677
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03773952
- **Lead sponsor:** Palobiofarma SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2021-05-27
- **Final completion:** 2021-05-27
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03773952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03773952, "Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03773952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*